Founded in 2017, Virohan operates in Edtech industry. Initially focused on addressing the skill gap in healthcare, Virohan has expanded its offerings to include a range of government-recognized progra...
Funding stage:
Series B
Last funding:
18/12/2025
Total funding:
$27.60 Mn+
Revenue:
Investors
Web traffic:
32.06K
32.06K
Last 30d
Last 30d
Glassdoor Rating:
Virohan: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders80
Latest Filing Date01 Dec 2025- Funding Events19
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Virohan
As of 02 December 2025, Virohan's equity is held by 79 shareholders, with the top three being Blume Ventures India Fund IV, Oxys Impact, and Kunaal Dudeja.
Blume Ventures India Fund IV holds the largest stake in Virohan at 13.7% as of 02 December 2025.
As of 02 December 2025, founders collectively hold 25.3% equity in Virohan.
As of 02 December 2025, investors collectively hold 47.3% equity in Virohan.
Virohan's ESOP pool stands at 8.2% of total equity as of 02 December 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links